TG Therapeutics | 営業利益

Operating Profit 変化する 日付
AbbVie USD 3.2B 914M 2023-12
Alaunos Therapeutics USD -8664000 682K 2023-09
Amgen USD 1.27B 819M 2023-12
Ardelyx USD 7.4M 24.02M 2023-09
Arrowhead Research USD -136545000 28.22M 2023-12
Bayer EUR -3594000000 2.64B 2023-09
Biogen USD 358.9M 200.1M 2023-12
Corcept Therapeutics USD 31.67M 492K 2023-12
Curis USD -12368000 230K 2023-09
Dynavax Technologies USD -8491000 13.61M 2023-12
Gilead Sciences USD 1.61B 1.01B 2023-12
Infinity Pharmaceuticals USD -10120000 1.39M 2023-06
J&J USD 4.83B 391M 2023-12
Novavax USD -125632000 181.09M 2023-09
PTC Therapeutics USD -131738000 13.57M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
TG Therapeutics USD -12485000 127.27M 2023-12
Verastem USD -21309000 1.02M 2023-09
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



TG Therapeutics 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2024.